Lv11
78 积分 2025-05-08 加入
Sacubitril-valsartan for the treatment of hypertension in China: A cost-utility analysis based on meta-analysis of randomized controlled trials
22天前
已完结
Transformer-based models for predicting cardiovascular risk in Chinese adults: development and validation
1个月前
已完结
Transformer-based models for predicting cardiovascular risk in Chinese adults: development and validation
1个月前
已完结
Familial Hypercholesterolemia Screening in Childhood and Early Adulthood
4个月前
已完结
Cost-Effectiveness of ApoB, Non–HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy
4个月前
已完结
Cost-Effectiveness of ApoB, Non–HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy
4个月前
已完结
Cost-Effectiveness of ApoB, Non–HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy
4个月前
已完结
Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy
4个月前
已关闭
Deriving Health Utility Values Using Mapping Methods Among the Chinese Population: A Systematic Review
11个月前
已完结
中国慢性肾脏病的发病率
1年前
已关闭
皖公网安备34019202002308
